Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
6.640
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1
Open
6.640
Bid (Size)
6.700 (4)
Ask (Size)
6.850 (1)
Prev. Close
6.640
Today's Range
6.640 - 6.640
52wk Range
5.035 - 15.74
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Peering Into Recursion Pharmaceuticals's Recent Short Interest
November 04, 2024
Via
Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session
November 04, 2024
Via
Benzinga
Performance
YTD
-32.73%
-32.73%
1 Month
+7.44%
+7.44%
3 Month
-1.92%
-1.92%
6 Month
-25.73%
-25.73%
1 Year
+20.07%
+20.07%
More News
Read More
Is Recursion Pharmaceuticals a Millionaire-Maker Stock?
November 02, 2024
Via
The Motley Fool
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
October 31, 2024
Via
Benzinga
Topics
ETFs
Stocks
Exposures
US Equities
Recursion to Report Third Quarter 2024 Business Updates and Financial Results on November 6th
October 30, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Is Recursion Pharmaceuticals Stock a Buy?
September 20, 2024
Via
The Motley Fool
Looking Into Recursion Pharmaceuticals's Recent Short Interest
September 16, 2024
Via
Benzinga
Decoding 6 Analyst Evaluations For Recursion Pharmaceuticals
September 04, 2024
Via
Benzinga
3 Key Trends That Are Bullish for Recursion Pharmaceuticals Stock
October 26, 2024
Via
The Motley Fool
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
October 22, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Prediction: These 2 Stocks Could Soar in 2025
October 17, 2024
Via
The Motley Fool
Cathie Wood Is Betting on This AI Stock: Is It a Buy?
October 15, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Down 57% in 2024, Is Recursion Pharmaceuticals a Buy on the Dip?
October 15, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
October 08, 2024
Via
The Motley Fool
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
October 07, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma
October 02, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
September 29, 2024
Via
The Motley Fool
AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week
September 15, 2024
Via
Talk Markets
AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th
September 10, 2024
Via
Talk Markets
These AI-Related Stocks Were Down +10% Week Ending September 6
September 07, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Interest Rates
Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!
September 05, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher
September 03, 2024
Via
Benzinga
Exposures
Fossil Fuels
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via
Benzinga
Nasdaq Dips Over 2%; US Construction Spending Falls In July
September 03, 2024
Via
Benzinga
Recursion Pharmaceuticals Stock Is Sliding Tuesday: What's Going On?
September 03, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.